Glenmark Pharmaceuticals informs about media release

03 Feb 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 03 February 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended?Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg’ which is self? explanatory

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2011.50 2.50 (0.12%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×